文献速递儿童呼吸儿童感染

针对性干预改善婴儿毛细支气管炎治疗:一项随机临床试验

Effectiveness of Targeted Interventions on Treatment of Infants With Bronchiolitis: A Randomized Clinical Trial.
PubMed 文献 · JAMA Pediatr · 2021-01-01

这项在澳大利亚和新西兰26家医院开展的国际多中心整群随机临床试验,比较针对性去实施干预与被动传播循证指南对毛细支气管炎婴儿治疗的影响。实施期共纳入3727例婴儿,干预组对首个24小时内不使用胸片、沙丁胺醇、糖皮质激素、抗生素和肾上腺素的依从率为85.1%,对照组为73.0%(调整风险差14.1%,95%CI 6.5%-21.7%,P<.001)。

要点

  • 针对性去实施干预可提高毛细支气管炎婴儿对循证指南的依从性。
  • 主要结局为首个24小时内不使用胸片、沙丁胺醇、糖皮质激素、抗生素和肾上腺素。
  • 干预组依从率85.1%,对照组73.0%,调整风险差14.1%(95%CI 6.5%-21.7%,P<.001)。

核心结论

  • 针对性干预较被动传播循证指南更能改善毛细支气管炎婴儿的治疗,减少低价值医疗。

研究设计与样本

  • 国际多中心整群随机临床试验,澳大利亚和新西兰26家提供三级或二级儿科诊疗的医院参与,13家分入干预组、13家分入对照组。

主要发现

  • 实施期3727例婴儿中,2328例(62%)为男孩、1399例(38%)为女孩,平均(SD)年龄6.0(3.2)个月;459例(12%)为新西兰毛利人,295例(8%)为澳大利亚原住民/托雷斯海峡岛民。
  • 干预组依从率为85.1%(95%CI 82.6%-89.7%),对照组为73.0%(95%CI 65.3%-78.8%),调整风险差14.1%(95%CI 6.5%-21.7%,P<.001)。

关键数值与推荐

  • 主要结局定义为首个24小时诊疗中不使用胸片、沙丁胺醇、糖皮质激素、抗生素和肾上腺素,依据随机选取的毛细支气管炎住院婴儿病历回顾性判定,无患者层面排除。
  • 干预措施基于行为改变理论,针对影响毛细支气管炎管理的关键因素,包括站点临床负责人、利益相关者会议、培训者培训工作坊、针对性教育、其他教育与宣传材料及审计反馈。

临床怎么用

  • 在儿科机构中可采用针对性去实施干预组合(临床负责人、教育、审计反馈等)以提高毛细支气管炎指南依从性、减少低价值治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: In developed countries, bronchiolitis is the most common reason for infants to be admitted to the hospital, and all international bronchiolitis guidelines recommend supportive care; however, significant variation in practice continues with infants receiving non-evidence-based therapies. Deimplementation research aims to reduce the use of low-value care, and advancing science in this area is critical to delivering evidence-based care. OBJECTIVE: To determine the effectiveness of targeted interventions vs passive dissemination of an evidence-based bronchiolitis guideline in improving treatment of infants with bronchiolitis. DESIGN, SETTING, AND PARTICIPANTS: This international, multicenter cluster randomized clinical trial included 26 hospitals (clusters) in Australia and New Zealand providing tertiary or secondary pediatric care (13 randomized to intervention, 13 to control) during the 2017 bronchiolitis season. Data were collected on 8003 infants for the 3 bronchiolitis seasons (2014-2016) before the implementation period and 3727 infants for the implementation period (2017 bronchiolitis season, May 1-November 30). Data were analyzed from November 16, 2018, to December 9, 2020. INTERVENTIONS: Interventions were developed using theories of behavior change to target key factors that influence bronchiolitis management. These interventions included site-based clinical leads, stakeholder meetings, a train-the-trainer workshop, targeted educational delivery, other educational and promotional materials, and audit and feedback. MAIN OUTCOMES AND MEASURES: The primary outcome was compliance during the first 24 hours of care with no use of chest radiography, albuterol, glucocorticoids, antibiotics, and epinephrine, measured retrospectively from medical records of randomly selected infants with bronchiolitis who presented to the hospital. There were no patient-level exclusions. RESULTS: A total of 26 hospitals were randomized without dropouts. Analysis was by intention to treat. Baseline data collected on 8003 infants for 3 bronchiolitis seasons (2014-2016) before the implementation period were similar between intervention and control hospitals. Implementation period data were collected on 3727 infants, including 2328 boys (62%) and 1399 girls (38%), with a mean (SD) age of 6.0 (3.2) months. A total of 459 (12%) were Māori (New Zealand), and 295 (8%) were Aboriginal/Torres Strait Islander (Australia). Compliance with recommendations was 85.1% (95% CI, 82.6%-89.7%) in intervention hospitals vs 73.0% (95% CI, 65.3%-78.8%) in control hospitals (adjusted risk difference, 14.1%; 95% CI, 6.5%-21.7%; P < .001). CONCLUSIONS AND RELEVANCE: Targeted interventions led to improved treatment of infants with bronchiolitis. This study has important implications for bronchiolitis management and the development of effective interventions to deimplement low-value care. TRIAL REGISTRATION: Australian and New Zealand Clinical Trials Registry: ACTRN12616001567415.

来源:JAMA Pediatr,查看原文。版权归原作者所有。

引用

  1. Haskell L, Tavender EJ, Wilson CL, et al. Effectiveness of Targeted Interventions on Treatment of Infants With Bronchiolitis: A Randomized Clinical Trial. JAMA Pediatr. 2021. PMID: 33843971. doi:10.1001/jamapediatrics.2021.0295

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。